Sometimes life is stranger than fiction. On paper, Raffles Medical share price should have risen steadily for the past 5 years because of increasing revenue and net profits. For most investors, that would be a reasonable assumption. In reality, Raffles Medical share price plummeted from $1.58 to the current $1.00 level. The massive correction of Raffles Medical share price represented a horrifying 37% decline within the span of three years. The unfolding meltdown of Raffles Medical share price must have scared the living daylight out of investors.
Sure, many analysts claim that the healthcare is an evergreen sector because of Singapore ageing population and that investors should stay calm. On this note, I do not disagree. In fact, revenue for Raffles Medical increased from $374million in FY2014 to $489million in FY2018. Net profits increased from $67million to $71million during this period. But against the backdrop of such consistently good financial performances, what were the intriguing dark forces behind the rupture of Raffles Medical share price?
Make no mistake, the devastating plunge of Raffles Medical share price would have wiped out whatever meagre dividends that investors collected for the past few years (assuming they had entered at the high of $1.58). Given the current Raffles Medical share price level, let’s examine whether the time is ripe to enter or avoid this counter.
Raffles Medical share price decline
First off, Standard Life Aberdeen stunned the market by selling 1.12 million shares on 26 February 2019. In the process, Standard Life Aberdeen ceased to be a substantial shareholder of Raffles Medical. That was a killer blow as Raffles Medical share price got bombed out, dropping from $1.10 and never looked back since. We all know support from the big boys is important, so obviously the market did not take the news kindly.
Then again, is it really the end of the road for Raffles Medical share price? To answer this question, there is a need to examine the Return on Equity (ROE) and evaluate the management’s strategy to stimulate growth. Determining these factors would provide the basis for future Raffles Medical share price movements.
ROE measures how efficient a company deploys the shareholder capital to generate returns. Simply put, if two companies generated the same amount of profits, the one that used a smaller working capital will have a higher ROE. To be frank, the data for Raffles Medical does [This is a premium article. The rest of the content is blocked and can be accessible by SG Wealth Builder Members only. To read the full content, please sign up as member.]
In a bid to raise financial literacy and reward SG Wealth Builder members, I am pleased to launch the Best SGX stock research campaign. Winner of this contest gets to receive cash prize of $1000!
The rationale for launching this activity is to level the playing field for retail investors, who often lack access to quality SGX stock research, especially homegrown SME stocks. Through this SGX stock research campaign, I hope to raise interest in SGX stocks among local investors, and at the same time, encourage members to share ideas and showcase their analytic skills. The winning entry will be published in this blog for learning purposes.
The winning SGX stock research article must cover a stock that is listed in Singapore Exchange (SGX) and should be engaging and interesting to read. From a story-telling perspective, you can share your best or worst SGX stock investments and what valuable lessons that can be gleaned. Ideally, the article should also contain data to back up the thesis and provides insightful analysis.
Winning prize: $1000
- This campaign is open to existing SG Wealth Builder Members only. If you are not a member, please sign up here. Email subscribers are not eligible.
- Each SG Wealth Builder member is entitled to submit one article only.
- Each article must be at least 1000 words in Microsoft Word document. Must not be published at any platform before. Any article found plagiarism would be automatically disqualified. You do not need to provide infographic or images but if you do, they must carry the applicable licenses.
- Email your submission to [email protected].com from 1 April 2019 to 31 May 2019. Late submission will not be entertained.
- In your document submission, you must provide your member userid or email address.
- The winning entry will be announced on 7 June 2019 and the winner will be notified through email. He/she must give the consent for the article to be published in this blog in order to receive the cash prize.
- In the event of a lack of quality submissions, there may be no winner. However, under such circumstances, consolation prizes may be given for entries that do not meet the evaluation criteria.
Not a member yet? You may sign up to become a member of SG Wealth Builder. The full benefits and privileges of SG Wealth Builder Membership:
- Access to the latest premium articles of SG Wealth Builder
- Email notifications of latest blog articles
- Participate in SG Wealth Builder campaigns
- Request for coverage on stocks, insurance and other personal financial topics
- Comment in articles and Wealth Forum
SG Wealth Builder Membership
You may sign up for the SG Wealth Builder Membership for only $15 per month. As a member, you can access all the articles, including the premium ones.
Note: After payment is made, you will be prompted with registration form to create your user-id and personal password.